SCHEMBL9019755

SCHEMBL9019755

CCOCC(COCC)OCn1cnc2nc(N)ncc21

nearest known ligand 0.32

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 1/20 0.32
HPGD P15428 1/20 0.32
ADRA1A P35348 1/20 0.32
HSD17B10 Q99714 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
ADORA2A P29274 2/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
CYP3A4 P08684 1/20 0.31
NFKB1 P19838 1/20 0.31
BLM P54132 1/20 0.31
VCP P55072 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9019861 0.87 ALDH1A1 (0.34) ALDH1A1KDM4EHPGDADRA1AHSD17B10
SCHEMBL9019744 0.86 ALDH1A1 (0.32) ALDH1A1KDM4EHPGDADRA1AHSD17B10
SCHEMBL8777006 0.86 KDM4E (0.35) ALDH1A1KDM4EHPGDADRA1AHSD17B10
SCHEMBL9019839 0.84 CDK1 (0.31)
SCHEMBL8205815 0.82 ALDH1A1 (0.38) ALDH1A1KDM4EHPGDADRA1AHSD17B10
SCHEMBL8210030 0.82 ALDH1A1 (0.48) ALDH1A1KDM4EHPGDADRA1AHSD17B10
SCHEMBL965011 0.82 ALDH1A1 (0.46) ALDH1A1KDM4EHPGDADRA1AHSD17B10
SCHEMBL8777020 0.81 ALDH1A1 (0.36) ALDH1A1KDM4EHPGDADRA1AHSD17B10
SCHEMBL8777015 0.81 PDE3A (0.40) ALDH1A1KDM4EHPGDADRA1AHSD17B10
SCHEMBL9845278 0.81 SYK (0.31) MEN1CYP3A4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0452680-B1 Substituted purines, process for their preparation and their use as antiviral agents HOECHST AG (DE) 1996-11-06 EP disclosed
EP-0452680-A1 Substituted purines, process for their preparation and their use as antiviral agents HOECHST AKTIENGESELLSCHAFT (DE) 1991-10-23 EP disclosed